Integris Medtech Ltd. is preparing to enter the primary market with a proposed IPO of approximately Rs.2,500–3,000 crore. According to a report by The Economic Times, the Gurugram-based medical products and laboratory solutions company is expected to open its public issue on 27 November and close on 1 December 2026. The proposed issue will comprise a fresh issue of shares and an offer for sale by existing shareholders.
The company operates across cardiovascular devices, clinical diagnostics and scientific laboratory solutions, supplying medical devices and laboratory products to international markets. It plans to utilise approximately 85% of the net proceeds from the fresh issue towards repayment or prepayment of borrowings at its wholly owned and step-down subsidiaries. The reported dates and issue size should be treated as proposed until confirmed through the final offer documents.
